Citius Oncology Inc. (CTOR) at a glance

Citius Oncology Inc. (CTOR) is a micro-cap Healthcare company. It trades at $0.6, with a 0% profit margin and revenue decline of 57.7%. It does not pay a dividend. Vestovix scores it 35/100 overall. Its strongest dimension is Value (53/100) and its weakest is Growth (12/100).

Price
$0.60
Market cap
$61.7M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$0.49 to $2.84
Vestovix Score35/ 100How this works
Value
53
Growth
12
Income
40
Safety
46
Momentum
16

Other Healthcare stocks

See all